Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A phase 2 study of Cis-platinum in patients with recurrent bladder carcinoma. The London and Oxford Co-operative Urological Cancer Group.

× No keyword cloud information.

6 in total

1. Phase II study of VP 16-213 (etoposide) in metastatic transitional cell urothelial cancer.

Authors: B A Ponder; R T Oliver
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

2. Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.

Authors: A Maru; H Akaza; S Isaka; K Koiso; T Kotake; T Machida; Y Matsumura; Y Nakagami; T Niijima; K Obata
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 3. Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Authors: R S Miller; F M Torti
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

Review 4. Landmarks in the treatment of muscle-invasive bladder cancer.

Authors: Niyati Lobo; Chloe Mount; Kawa Omar; Rajesh Nair; Ramesh Thurairaja; Muhammad Shamim Khan
Journal: Nat Rev Urol Date: 2017-07-04 Impact factor: 14.432

5. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.

Authors: C Mulatero; B R McClaren; M Mason; R T Oliver; C J Gallagher
Journal: Br J Cancer Date: 2000-12 Impact factor: 7.640

Review 6. Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options.

Authors: Inkeun Park; Jae Lyun Lee
Journal: Korean J Intern Med Date: 2020-07-01 Impact factor: 2.884

6 in total